Abstracts Archive - Page 122 of 1683 - ATC Abstracts

2022 American Transplant Congress
En-Bloc Kidney Transplantation in Children Over a 33-year Period in USA – A Comparative Study
P. Gogalniceanu¹, I. D. Kostakis², P. Chandak³, G. Papadakis⁴, J. Stojanovic⁵, F. Calder⁴, I. Loukopoulos⁴, N. Kessaris⁴
¹Abdominal Transplant Surgery, Guy's Hospital, London, London, United Kingdom, ²Department of HPB Surgery and Liver Transplantation, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, United Kingdom, ³Transplantation, Guy's and St Thomas Hospitals NHS Trust and King's College London, London, United Kingdom, ⁴Guy's Hospital, London, United Kingdom, ⁵Great Ormond Street Hospital, London, United Kingdom
*Purpose: En-bloc kidney transplantation is not commonly performed due to scarcity of such organs as well as due to potential technical and thrombotic problems. We…
2022 American Transplant Congress
Long Term Analysis of Pediatric En-Bloc Kidney Transplantation: A Single Center Experience
H. H. Patel¹, P. Di Cocco², J. Almario², A. Fratti², S. Akshelyan², E. Benedetti², I. Tzvetanov², M. Spaggiari²
¹University of Missouri-Kansas City School of Medicine, Kansas City, MO, ²University of Illinois at Chicago, Chicago, IL
*Purpose: Pediatric en-bloc kidney transplantations for adult recipients are uncommonly performed due to unique donor characteristics, the technical challenge of the operation, and potential surgical…
2022 American Transplant Congress
Characterizing the Landscape of Cancer Risk Following HLA-Incompatible Living Donor Kidney Transplantation
J. D. Motter¹, K. Jackson¹, K. Yu², R. M. Pfeiffer², A. Massie¹, J. Garonzik-Wang³, D. Segev¹, E. A. Engels²
¹Johns Hopkins University, Baltimore, MD, ²National Cancer Institute, Bethesda, MD, ³University of Wisconsin-Madison, Madison, WI
*Purpose: Incompatible living donor kidney transplant recipients (ILDKTr) require desensitization to facilitate transplantation across donor-specific antibody (DSA); however, this substantial upfront immunosuppression may result in…
2022 American Transplant Congress
Area Deprivation Index is Associated with Worse Patient Survival Following Adult Liver Transplantation
J. Hendele¹, J. Perkins², J. Nichols³, A. Dick¹
¹Division of Transplant Surgery, Department of Surgery, University of Washington, Seattle, WA, ²Clinical and Bio-Analytics Transplant Laboratory (CBATL), University of Washington, Division of Transplant Surgery, Department of Surgery, Seattle, WA, ³School of Medicine, University of Washington, Seattle, WA
*Purpose: Area Deprivation Index (ADI) has been utilized as a granular measure of local socioeconomic status for nearly two decades. This study is the first…
2022 American Transplant Congress
130 Totally Robotic Donor Hepatectomy: Reproducibility Of A Standardized Technique Across 2 Specialized Centers
Y. Cheah¹, H. Yang², C. J. Simon¹, J. Kim³, M. Akoad³, G. Choi²
¹Roger L Jenkins Transplant Institute, Lahey Hospital & Medical Center, Burlington, MA, ²Division of HPB Surgery, Yonsei University College of Medicine, Seoul, Korea, Republic of, ³Lahey Hospital & Medical Center, Burlington, MA
*Purpose: Robotic surgery is emerging as a feasible though complex technique to enable minimally-invasive donor hepatectomy.*Methods: First multicenter prospective study on 130 consecutive totally robotic…
2022 American Transplant Congress
The Other Reasons for Waitlist Removal
C. Martinez, J. Foutz, A. Placona, L. Cartwright
United Network for Organ Sharing, Richmond, VA
*Purpose: When a transplant program removes a candidate from the waitlist, they must either select a pre-defined removal code or type a response into the…
2022 American Transplant Congress
Tabelecleucel (Tab-cel) for Solid Organ (SOT) or Allogeneic Hematopoietic Cell Transplant (HCT) Recipients with Epstein-Barr Virus-Driven Post Transplant Lymphoproliferative Disease (EBV⁺ PTLD) After Failure Of Rituximab (R) ± Chemotherapy (CT) (ALLELE)
S. Prockop¹, A. Beitinjaneh², S. Choquet³, S. Dahiya⁴, R. Dinavahi⁵, R. Farah⁶, L. Gamelin⁵, A. Joshi⁵, A. Mehta⁵, P. Nayak⁵, R. Reshef⁷, G. Satyanarayana⁸, P. Stiff⁹, W. Ye⁵, K. M. Mahadeo¹⁰
¹Boston Children's Hospital/Dana Farber Cancer Institute, Boston, MA, ²University of Miami/Jackson Memorial Hospital, Miami, FL, ³Sorbonne Université, Hôpital de la Pitié-Salpêtrière, Paris, France, ⁴University of Maryland School of Medicine, Baltimore, MD, ⁵Atara Biotherapeutics, South San Francisco, CA, ⁶UPMC Hillman Cancer Center, Pittsburgh, PA, ⁷Columbia University Medical Center, NY, NY, ⁸Ingram Cancer Center, Vanderbilt Health, Nashville, TN, ⁹Loyola University Medical Center, Chicago, IL, ¹⁰MD Anderson Cancer Center, Houston, TX
*Purpose: Tab-cel is an investigational, off-the-shelf, allogeneic EBV-specific T-cell immunotherapy for serious EBV-driven diseases, including EBV+ PTLD. Poor overall survival (OS) in patients (pts) with…
2022 American Transplant Congress
Long-Term Outcomes for Living Kidney Donors with Early Guideline-Concordant Follow-Up Care
A. Dhalla¹, A. Lloyd², K. L. Lentine³, A. X. Garg⁴, R. R. Quinn¹, P. Ravani¹, S. W. Klarenbach², B. R. Hemmelgarn², U. Ibelo¹, N. N. Lam¹
¹Department of Medicine, Division of Nephrology, University of Calgary, Calgary, AB, Canada, ²Department of Medicine, Division of Nephrology, University of Alberta, Edmonton, AB, Canada, ³Center for Abdominal Transplantation, Saint Louis University, St. Louis, MO, ⁴Department of Medicine, Division of Nephrology, Western University, London, ON, Canada
*Purpose: Current guidelines recommend that living kidney donors receive annual lifelong follow-up to monitor kidney health. It is unclear whether early guideline-concordant care is associated…
2022 American Transplant Congress
Establishing a Framework for Long-Term Follow-Up: A Survey of Perspectives and Preferences of Living Kidney Donors
S. K. Singh¹, N. Caton², O. Johnston², C. S. Hanson³, A. Dominello³, K. Yetzer⁴, D. Chang², A. Tong³, J. S. Gill²
¹Department of Medicine, University of Toronto, Toronto, ON, Canada, ²Department of Medicine, University of British Columbia, Vancouver, BC, Canada, ³Sydney School of Public Health, University of Sydney, Sydney, Australia, ⁴Canadian Blood Services, Ottawa, ON, Canada
*Purpose: There is currently no established standard for long-term follow-up of living kidney donors in Canada. To inform a new national standard, we sought to…
2022 American Transplant Congress
More Than Just Drain Pipes, Pulmonary Lymphatics Play a Pivotal Role in the Development of Bronchiolitis Obliterans Syndrome
L. Wang¹, R. Han², H. Outtz Reed³, W. W. Hancock²
¹Childrens Hospital of Phila, Philadelphia, PA, ²Children's Hospital of Philadelphia, Philadelphia, PA, ³Weill Cornell, New York, NY
*Purpose: Chronic allograft dysfunction (CLAD) remains a major determinant of the generally poor long-term outcome of lung transplantation compared to that of other solid organ…